Authors
Yan Valle, Torello Lotti, Julia Sigova, Davinder Parsad
Published in
International journal of dermatology. Sep 15, 2026. Epub Sep 15, 2026.
Abstract
Vitiligo entails three therapeutic objectives: control of autoimmune activity, restoration of melanocyte function, and interruption of disease memory. Distinguishing these goals can refine clinical management, trial endpoints, and therapeutic development in vitiligo and other immune-mediated skin diseases.
PMID:
42742316
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0